Analyst firms · Guggenheim · GNRC

Guggenheim GNRC price target and rating history

Generac Holdlings Inc. (GNRC) · Consumer Discretionary

Guggenheim rates Generac Holdlings Inc. (GNRC) Neutral with a $202 price target, as of its latest action on Feb 12, 2026. It has published 8 rating actions on GNRC since December 2022, including 3 upgrades and 4 downgrades. Across 10 firms with a GNRC price target in the last 12 months, the median target is $285. Guggenheim's $202 is 29% below that.

Current rating
Neutral
Price target
$202
Median target, all firms
$285
Actions on GNRC
8

Guggenheim price target on GNRC

$202$161$1202023202420252026
Guggenheim price target on GNRC, each point a stated target, December 2022 to February 2026.

Every Guggenheim rating on GNRC

How other firms rate GNRC

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Piper SandlerOverweight$303Oct 8, 2026
KeyBanc Capital MarketsOverweight$280Oct 8, 2026
Cantor FitzgeraldOverweight$325Jul 22, 2026
BarclaysEqual Weight$285Jun 29, 2026
UBSBuy$335Jun 11, 2026
JefferiesBuy$302May 22, 2026
TD CowenBuy$285Apr 30, 2026
CitigroupNeutral$237Mar 12, 2026
GuggenheimNeutral$202Feb 12, 2026
Robert W. BairdOutperformJan 9, 2026
Wells FargoOverweight$195Dec 19, 2025

Questions about Guggenheim and GNRC

What is Guggenheim's price target for GNRC?
Guggenheim's latest stated price target for Generac Holdlings Inc. (GNRC) is $202, from its action on Feb 12, 2026.
What is Guggenheim's rating on GNRC?
Guggenheim rates GNRC Neutral, a neutral rating, as of Feb 12, 2026.
When did Guggenheim last change its view on GNRC?
On Feb 12, 2026, Guggenheim downgrades to Neutral from Buy, price target $202.
How does Guggenheim's GNRC target compare with other analysts?
Across 10 firms with a GNRC price target in the last 12 months, the median target is $285. Guggenheim's $202 is 29% below that.

More GNRC rating histories

All Guggenheim ratingsGNRC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.